“The T3M approach to insulin delivery offers real potential for faster insulin action to improve predictability and responsiveness, making it possible to approach normal insulin dynamics. Coupled with responsive salivary glucose sensing, a novel approach to an effective artificial pancreas system is in the making.”
– Ananda Basu M.B.B.S., MD (Mayo Clinic Rochester)
These Three Medical Inc. is a for profit, social purpose corporation formed to address the medical needs of those afflicted with diabetes through innovative therapies that leverage advancement in microelectronics, physiological sensing technologies, data analysis and communications, integrated together with optimal control algorithms and delivery approaches, thereby offering the best in responsive therapy. In every T3M endeavor we desire to act justly and serve with mercy, humbly drawing upon God’s wisdom to do the most public good possible by minimizing the clinical and economic burden of diabetes.
“Approaches to insulin delivery and closed loop control that can circumvent these problems (peripheral sensing and delivery) are very interesting and need further detailed study. I am therefore intrigued by the approaches proposed by T3M. This sort of ‘out of the box’ thinking is exactly what we need, and is potentially curative.”
– Alan D. Cherrington, Ph.D (Vanderbilt University Medical Center)
A Social Purpose Corporation
Our specific public benefit: These Three Medical Inc. intends to address the medical needs of those afflicted with diabetes through innovative therapies that leverage advancement in microelectronics, physiological sensing technologies, data analysis and communications, integrated together with optimal control algorithms and delivery approaches, thereby offering the best in responsive therapy while mitigating patient burden. T3M will provide all reasonable efforts to insure that the technologies and therapies proposed will be available to those in need regardless of ability to pay. The directors and management of the company shall equally balance the responsibility we have to those we serve with maximizing the financial return to our shareholders. Company directors and management must give strong consideration to this special purpose in any of its decision making processes, and endeavor to ensure that the commercialization of company developments are diligently and aggressively pursued in a way that reaches all who may benefit. Furthermore, should lack of income, insurance, or other personal challenges preclude future customers from paying the full sales price our products, These Three Medical Inc. Senior Management shall be empowered to seek creative funding, alternate means of distribution and or provide aggressive discounts.